Acuta Capital Partners, LLC Kura Oncology, Inc. Transaction History

Acuta Capital Partners, LLC

$98.8 Million
Q3 2024

A detailed history of Acuta Capital Partners, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 197,000 shares of KURA stock, worth $1.77 Million. This represents 3.9% of its overall portfolio holdings.

Number of Shares

197,000

Previous 163,000 20.86%

Holding current value

$1.77 Million

Previous $3.36 Million 14.69%

% of portfolio

3.9%

Previous 3.61%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $631,380 - $789,820	34,000 Added 20.86%	197,000 $3.85 Million
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $1.28 Million - $1.68 Million	73,000 Added 81.11%	163,000 $3.36 Million
Q1 2024 May 15, 2024	SELL	$13.42 - $23.53 $8.2 Million - $14.4 Million	-611,349 Reduced 87.17%	90,000 $1.92 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $5,639 - $10,698	-744 Reduced 0.11%	701,349 $10.1 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $59,291 - $83,316	-7,025 Reduced 0.99%	702,093 $6.4 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $1.38 Million - $2.01 Million	143,861 Added 25.45%	709,118 $7.5 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $682,837 - $930,852	63,757 Added 12.71%	565,257 $6.91 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $393,050 - $591,500	-35,000 Reduced 6.52%	501,500 $6.22 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $669,707 - $1.15 Million	62,531 Added 13.19%	536,500 $9.83 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $2.14 Million - $3.09 Million	182,085 Added 62.38%	473,969 $7.62 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $948,545 - $1.34 Million	-61,514 Reduced 17.41%	291,884 $5.47 Million
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $3.82 Million - $5.48 Million	-183,422 Reduced 34.17%	353,398 $7.37 Million
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $2.49 Million - $3.94 Million	-100,680 Reduced 15.79%	536,820 $15.2 Million
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $9.73 Million - $14 Million	-335,500 Reduced 34.48%	637,500 $20.8 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $1.64 Million - $3.08 Million	100,500 Added 11.52%	973,000 $29.8 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $5.36 Million - $12.7 Million	674,500 Added 340.66%	872,500 $14.2 Million
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $270,900 - $589,680	-42,000 Reduced 17.5%	198,000 $1.97 Million
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $1.88 Million - $2.31 Million	145,000 Added 152.63%	240,000 $3.3 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $1.4 Million - $1.98 Million	95,000 New	95,000 $1.44 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Account

Acuta Capital Partners, LLC Kura Oncology, Inc. Transaction History